ABOUT US
Established in 1995, Charles Thomas & Partners is a boutique corporate advisory firm assisting small and medium sized companies in the life sciences and technology sectors.
Our mission is to allow businesses with novel ideas, disruptive technologies and exceptional founders/management to leverage our business development, fund raising, M&A and cross-border expertise to foster rapid growth and value acceleration.
Founded on the principles of integrity: how business is conducted, knowledge: the foundational skills, thought: the value-added experience & expertise, momentum: delivering timely results and dedication: a strong customer-focus, we have been assisting businesses for over two decades with strategic partnerships, private placements, debt financing, mergers, acquisitions, buyouts and going public.
ADVISORY SERVICES
TEAM
Key Personnel
Christopher Wong
Christopher Wong is the Managing Partner at Charles Thomas and a General Partner of CT Ventures. He has over 28 years of experience in the corporate, finance, management and strategy arena, specialising in working with life sciences and tech companies to raise capital, enhance shareholder value and improve operational efficiency. He was a co-founder of Klarity, an analytics business focused on Asia social data, which was acquired by Meltwater where he is still currently a director. He is also an Advisor of Greenwing Ventures, an agri-tech-centric consulting firm, and an Senior Associate of Evans & Evans Inc., a Vancouver, Canada-based investment banking firm.
Advisors
Dr. Milton Wong M.D., F.R.C.P. (C)
Milton Wong is a neurologist with over 50 years of clinical medical experience and over 25 years of clinical trial experience, specialising in Stroke research. He is Clinical Associate Professor (Emeritus) at St. Paul’s Hospital (Vancouver, Canada) and previously Division Head of Neurology at St. Paul’s Hospital, an Associate Professor at the University of British Columbia and a Director on the Board of the British Columbia Heart and Stroke Foundation. He also help establish Acute Stroke Care in British Columbia, Canada, the CHOI Scholarship for Training Asian Speaking Neurologists and the Neurology Continuing Education Fund at St. Paul’s Hospital.
Moira Fong LL.B.
Moria Fong is a barrister and solicitor who was called to the Canadian bar in 1996. Previously she was with Alexander Holburn Beaudin & Lang LLP (Vancouver, Canada) and on Faculty at Capilano University teaching in the Department of Legal Studies. Before retiring, she was a member of the Law Society of British Columbia and the Canadian Bar Association. Currently she serves on various non-profit committees and executive boards.
VENTURE CAPITAL
CT Early Stage Venture Capital Fund
The fund is focused on identifying and investing in health & tech opportunities with innovative, disruptive technologies that are driven by passionate, world-class founders.
Investment focus are start-ups and early stage capital efficient life sciences/technology companies within the following strategic sectors:
We target businesses where we have the ability to enhance performance and fuel growth. Our philosophy is to foster long-term partnerships, a “hands-on” approach and working side-by-side with founders through each stage of development. We back people with our financial, management, operational and technical knowledge to build and scale from innovation to commercialisation.
We particularly look for opportunities that can leverage our cross-border (Asia/North America) expertise. Typical initial investment size is between USD500K – 1M.
CONTACT US
Contact Form
Hong Kong Office
20th Floor, Central Tower,
28 Queen's Road Central,
Hong Kong
